Shokri Hoda, Ali Ihab, Kasem Amr A
Department of Anesthesiology, Ain Shams University, Cairo, Egypt.
Department of Cardiothoracic Surgery, Ain Shams University, Cairo, Egypt.
Local Reg Anesth. 2021 Nov 12;14:145-152. doi: 10.2147/LRA.S338685. eCollection 2021.
Transverse thoracic block is a new perioperative analgesic method for post-sternotomy discomfort. This study discusses the efficacy of an ultrasound-guided transversus thoracic muscle plane block (TTPB) in patients undergoing heart surgery, including sternotomy.
In this prospective trial, 60 patients were randomly assigned to two groups: transversus (T) or general anesthesia (GA). Patients in the T group received TTPB with GA and 15 mL of 0.25% bupivacaine was administered on either side. Patients in the GA group received TTPB along with GA, but 15 mL saline was injected on either side instead. The patients were followed up postoperatively. The percentage of patients receiving additional opioids, extubation time, intensive care unit (ICU) length, postoperative morphine dose, and adverse events were documented.
The percentage of patients requiring additional morphine was significantly lower in the T group (p<0.015). Pain scores were comparable between the groups at extubation time and 18 h postoperatively. At 8, 12, and 24 h after surgery, pain scores in the T group were significantly lower (P<0.001). The total amount of morphine required after surgery was much lower in the T group (8±0.74 mg), and the duration to initial analgesic necessity was significantly greater in the GA group (P<0.001). Patients in the GA group had a considerably longer ventilation time (11.07±0.64) (P<0.001). The ICU stay in the T group was substantially shorter (P<0.001), and postoperative complications were comparable.
For patients undergoing heart surgery, TTPB offers sufficient postoperative pain control, resulting in lower pain scores, lower postoperative analgesic doses, shorter extubation times, and shorter ICU stay lengths.
横向胸段阻滞是一种用于胸骨切开术后不适的新型围手术期镇痛方法。本研究探讨超声引导下胸横肌平面阻滞(TTPB)在包括胸骨切开术在内的心脏手术患者中的疗效。
在这项前瞻性试验中,60例患者被随机分为两组:横肌平面阻滞(T)组或全身麻醉(GA)组。T组患者在全身麻醉下行TTPB,每侧注射15 mL 0.25%布比卡因。GA组患者在全身麻醉下行TTPB,但每侧注射15 mL生理盐水。对患者进行术后随访。记录接受额外阿片类药物治疗的患者百分比、拔管时间、重症监护病房(ICU)住院时间、术后吗啡剂量和不良事件。
T组需要额外吗啡治疗的患者百分比显著更低(p<0.015)。两组在拔管时和术后18小时的疼痛评分相当。术后8、12和24小时,T组的疼痛评分显著更低(P<0.001)。T组术后所需吗啡总量更低(8±0.74 mg),GA组至首次需要镇痛的时间显著更长(P<0.001)。GA组患者的通气时间明显更长(11.07±0.64)(P<0.001)。T组的ICU住院时间明显更短(P<0.001),术后并发症相当。
对于接受心脏手术的患者,TTPB可提供充分的术后疼痛控制,导致疼痛评分更低、术后镇痛剂量更低、拔管时间更短和ICU住院时间更短。